Site Under Construction

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma in a 76-year-old Filipino Male: a case report

Katrina M. Canlas-Estrella, MD, DPDS, Joshua A. Arcaira, MD, DPDS, Filomena Legarda-Montinola, MD, FPDS, Teresita E. Dumagay, MD, FPCP

Abstract

Introduction

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma (PCAECTCL) is a rare subtype of cutaneous T-cell lymphoma characterized by widely distributed ulcerated lesions, epidermotropic infi ltrates of CD8+ cytotoxic T cells, aggressive course, high tendency to spread to extranodal sites, poor response to conventional therapies and unfavorable prognosis.

Case Report

We report a 76-year-old Filipino male presenting with eight-month history of erythematous scaly patches evolving into widespread ulcerated nodules, unresponsive to topical and systemic steroids. Histopathology revealed prominent epidermotropism and lichenoid infi ltrate of atypical lymphocytes. Immunohistochemistry showed positivity for CD3, CD8, Ki67 (5-15%), CD7, CD2; indeterminate for TIA-1, with high background staining; and was negative for CD20, CD30, CD4, CD5, CD56, granzyme-B, TdT, Epstein-Barr encoding region in situ hybridization (EBER-ISH), consistent with PCAECTCL. No overt metastasis was detected. The patient underwent interferon alfa 2B therapy followed by three full cycles of CHOP chemotherapy. Improvement was seen as thinning of plaques and nodules and re-epithelialization of ulcers however, severe anemia and leukopenia ensued with therapy. He then succumbed to septic shock secondary to pneumonia during the height of the COVID-19 pandemic.

Conclusion

This case emphasizes that despite accurate diagnosis, polychemotherapy, and favorable response to therapy, complications may still arise contributing to the poor prognosis and low five-year survival rate of this condition.

References

  1. Nofal A, Abdel-Mawla MY, Assaf M, Salah E. (2012). Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation. J Am Acad Dermatol. 67:748–59.
  2. Willemze, R., Cerroni, L., Kempf, W., Berti, E., Facchetti, F., Swerdlow, S. H., & Jaff e, E. S. (2019). The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood, blood–2018–11–881268.
  3. Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaff e E, Dummer R, Berti E, Cerroni L, Chimenti S, Diaz-Perez J, Grange F, Harris N, Kazakov D, Kerl H, Kurrer M, Knobler R, Meijer C, Pimpinelli N & Whittaker S. (2005). WHO/EORTC classifi cation of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32; 647-74.
  4. Robson A, Assaf C, Bagot M, Burg G, Calonje E, Castillo C, Cerroni L, Chimenti N, Dechelotte P, Franck F, Geerts M, Gellrich S, Goodlad J, Kempf W, Knobler
    R, Massone C, Meijer C, Ortiz P, Petrella T, Pimpinelli N, Roewert J, Russell-Jones R, Santucci M, Steinhoff M, Sterry W, Wechsler J, Whittaker S, Willemze R, Berti E. (2015). Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology. 67(4):425-41. doi: 10.1111/his.12371. Epub 2015 Feb 24.
  5. Gormley, RH, Hess, SD, Anand D, Junkins-Hopkins, J, Rook, AH, Kim EJ. (2010). Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. J
    Am Acad Dermatol. 62:300-7.
  6. Ma, X, Wu, Y, Zhang, T, Song, H, Jv, H, Guo, W, Ren G (2017). Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral
    Mucosal Melanoma in Patients without Distant Metastases. Journal of Cancer, 8(18), 3828-3837.
  7. Raghavan, SS & Kim, J. (2018). Histopathologic approach to epidermotropic lymphocytic infi ltrates. Clin Cutan Med Surg 37:56-60.
  8. Walsh, N. M. G., Prokopetz, R., Tron, V. A., Sawyer, D. M., Kevin Walters, A., Murray, S., & Zip, C. (1994). Histopathology in erythroderma: review of a series of cases by multiple observers. Journal of Cutaneous Pathology, 21(5), 419–423.
  9. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Muller-Hermelink HK, et al. Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC
    cutaneous lymphoma task force workshop. Cancer 2003;97:610-27.
  10. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. (1999). Primary cutaneous CD8-positive epidermotropic cytotoxic T-cell lymphomas: a
    distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 1999; 155:483-492.
  11. Scarisbrick, J. J. (2006). Staging and management of cutaneous T-cell lymphoma. Clinical and Experimental Dermatology, 31(2), 181-186.
  12. Gormley, RH, Hess, SD, Anand D, Junkins-Hopkins, J, Rook, AH, Kim EJ. (2010). Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. J Am Acad Dermatol. 62:300-7.
  13. Nofal, A, Abdel-Mawla, MY, Assaf, M, Salah, E, Abd-Elazim, H. (2014). Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma: a diagnostic and therapeutic challenge. Int J Dermatol; 53:76-81.
  14. Cyrenne, BM, Subtil A, Girardi, M, Foss, F. (2017). Primary cutaneous aggressive epidermotropic cytotoxic CD8+ T-cell lymphoma: long-term remission
    after brentuximab vedotin. Int J Dermatol, 56(12), 1448-1450.
  15. Cyrenne, BM, Gibson, JF, Subtil, A, Girardi, M, Isufi , I, Seropian, S, Foss, F. (2018). Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cyotoxic CD8-positive T-cell Lymphoma. Clinical Lymphoma, Myeloma, & Leukemia, 18(1), e85-e93.

REquesting Permission

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma in a 76-year-old Filipino Male: a case report